{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:43:19Z","timestamp":1771479799997,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.mce.2022.111757","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T02:19:26Z","timestamp":1661739566000},"page":"111757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Vitamin D receptor activation is a feasible therapeutic target to impair adrenocortical tumorigenesis"],"prefix":"10.1016","volume":"558","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9043-9831","authenticated-orcid":false,"given":"Ana Carolina","family":"Bueno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7950-0363","authenticated-orcid":false,"given":"Candy Bellido","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junier","family":"Marrero-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7308-6747","authenticated-orcid":false,"given":"Danillo C.","family":"de Almeida e Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2200-3985","authenticated-orcid":false,"given":"Leticia Ferro","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Montaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Silva","family":"Ramalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0425-7877","authenticated-orcid":false,"given":"Ricardo Zorzetto Nicoliello","family":"V\u00eancio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4778-8803","authenticated-orcid":false,"given":"Sonir Roberto R.","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2022.111757_bib1","doi-asserted-by":"crossref","first-page":"84634","DOI":"10.18632\/oncotarget.12382","article-title":"Unraveling the expression of the oncogene YAP1, a Wnt\/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients","volume":"7","author":"Abduch","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2022.111757_bib2","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/carcin\/bgm094","article-title":"The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells","volume":"28","author":"Aguilera","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mce.2022.111757_bib3","series-title":"FASTQC. A Quality Control Tool for High Throughput Sequence Data","author":"Andrews","year":"2010"},{"key":"10.1016\/j.mce.2022.111757_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/17446651.2014.941813","article-title":"Pediatric adrenocortical tumors: diagnosis, management and advancements in the understanding of the genetic basis and therapeutic implications","volume":"9","author":"Antonini","year":"2014","journal-title":"Expet Rev. Endocrinol. Metabol."},{"key":"10.1016\/j.mce.2022.111757_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mce.2022.111757_bib6","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1210\/en.2009-1139","article-title":"Functional roles of protein kinase A (PKA) and exchange protein directly activated by 3',5'-cyclic adenosine 5'-monophosphate (cAMP) 2 (EPAC2) in cAMP-mediated actions in adrenocortical cells","volume":"151","author":"Aumo","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2022.111757_bib7","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1073\/pnas.85.10.3294","article-title":"Cloning and expression of full-length cDNA encoding human vitamin D receptor","volume":"85","author":"Baker","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2022.111757_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007872","article-title":"Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines","volume":"4","author":"Beildeck","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2022.111757_bib9","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.mce.2022.111757_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mce.2022.111757_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1530\/EJE-21-0879","article-title":"Vitamin D receptor hypermethylation as a biomarker for pediatric adrenocortical tumors","volume":"186","author":"Bueno","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2022.111757_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0960-0760(95)00128-M","article-title":"Modulation of vitamin D receptor and estrogen receptor by 1,25(OH)2-vitamin D3 in T-47D human breast cancer cells","volume":"54","author":"Davoodi","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2022.111757_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/bs.vh.2015.11.002","article-title":"Analogs of 1\u03b1,25-dihydroxyvitamin D\u2083 in clinical use","volume":"100","author":"DeLuca","year":"2016","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.mce.2022.111757_bib14","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1210\/jc.2008-0247","article-title":"The T cell factor\/beta-catenin antagonist PKF115-584 inhibits proliferation of adrenocortical carcinoma cells","volume":"93","author":"Doghman","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2022.111757_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.critrevonc.2017.02.015","article-title":"Vitamin D analogues: potential use in cancer treatment","volume":"112","author":"Duffy","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.mce.2022.111757_bib16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2022.111757_bib17","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98m","author":"Fassnacht","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2022.111757_bib18","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2022.111757_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105434","article-title":"The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: a possible calcium metabolism-associated aberrant \"neoplastic\" steroidogenesis in adrenals","volume":"193","author":"Gao","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2022.111757_bib20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1158\/1078-0432.CCR-10-2006","article-title":"\u03b2-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma","volume":"17","author":"Gaujoux","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2022.111757_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055743","article-title":"Silencing mutated \u03b2-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R","volume":"8","author":"Gaujoux","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2022.111757_bib22","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.mce.2022.111757_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/bjc.1998.434","article-title":"A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer","volume":"78","author":"Gulliford","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mce.2022.111757_bib24","doi-asserted-by":"crossref","first-page":"79292","DOI":"10.18632\/oncotarget.12685","article-title":"Targeting heterogeneity of adrenocortical carcinoma: evaluation and extension of preclinical tumor models to improve clinical translation","volume":"7","author":"Hantel","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2022.111757_bib25","doi-asserted-by":"crossref","first-page":"16304","DOI":"10.18632\/oncotarget.4059","article-title":"Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of \u03b2-catenin activity","volume":"6","author":"Johnson","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2022.111757_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.abb.2011.11.003","article-title":"25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D","volume":"523","author":"Jones","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mce.2022.111757_bib27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1530\/ERC-17-0447","article-title":"Development of new preclinical models to advance adrenocortical carcinoma research","volume":"25","author":"Kiseljak-Vassiliades","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2022.111757_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222010981","article-title":"ATP1A1 mutant in aldosterone-producing adenoma leads to cell proliferation","volume":"22","author":"Kobuke","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2022.111757_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096695","article-title":"Vitamin D up-regulates the vitamin D receptor by protecting it from proteasomal degradation in human CD4+ T cells","volume":"9","author":"Kongsbak","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2022.111757_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1530\/EJE-20-1423","article-title":"A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden","volume":"184","author":"Landwehr","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2022.111757_bib31","doi-asserted-by":"crossref","first-page":"43016","DOI":"10.18632\/oncotarget.5513","article-title":"Inhibition of the Tcf\/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis","volume":"6","author":"Leal","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2022.111757_bib32","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1210\/jc.2011-0363","article-title":"Wnt\/beta-catenin pathway deregulation in childhood adrenocortical tumors","volume":"96","author":"Leal","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2022.111757_bib33","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M115.693614","article-title":"Mechanisms of enhancer-mediated hormonal control of vitamin D receptor gene expression in target cells","volume":"290","author":"Lee","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111757_bib34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fphys.2014.00122","article-title":"The future of vitamin D analogs","volume":"5","author":"Leyssens","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.mce.2022.111757_bib35","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/endo.141.9.7668","article-title":"Establishment and characterization of a human adrenocortical carcinoma xenograft model","volume":"141","author":"Logi\u00e9","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2022.111757_bib36","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/jcp.24847","article-title":"Vitamin D receptor and RXR in the post-genomic era","volume":"230","author":"Long","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.mce.2022.111757_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1530\/EJE-12-0183","article-title":"Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis","volume":"167","author":"Lorea","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2022.111757_bib38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.mce.2022.111757_bib39","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.bbalip.2010.04.009","article-title":"1alpha,25-Dihydroxyvitamin D3 affects hormone production and expression of steroidogenic enzymes in human adrenocortical NCI-H295R cells","volume":"1801","author":"Lundqvist","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2022.111757_bib40","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.bbagen.2012.04.017","article-title":"Vitamin D-mediated regulation of CYP21A2 transcription - a novel mechanism for vitamin D action","volume":"1820","author":"Lundqvist","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2022.111757_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The clinically inapparent adrenal mass: update in diagnosis and management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2022.111757_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2016.03.013","article-title":"Regulation of vitamin D receptor expression by retinoic acid receptor alpha in acute myeloid leukemia cells","volume":"159","author":"Marchwicka","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2022.111757_bib43","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1210\/jc.2017-02591","article-title":"Mitotane monotherapy in patients with advanced adrenocortical carcinoma","volume":"103","author":"Megerle","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2022.111757_bib44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/cen.12462","article-title":"Altered expression of noncanonical Wnt pathway genes in paediatric and adult adrenocortical tumours","volume":"81","author":"Mermejo","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.mce.2022.111757_bib45","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1210\/js.2018-00197","article-title":"Therapeutic targets for adrenocortical carcinoma in the genomics era","volume":"2","author":"Mohan","year":"2018","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.mce.2022.111757_bib46","first-page":"198","article-title":"Pituitary-adrenal responses to corticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency","volume":"74","author":"Moreira","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2022.111757_bib47","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1158\/0008-5472.CAN-18-3927","article-title":"Vitamin D-VDR signaling inhibits Wnt\/\u03b2-catenin-mediated melanoma progression and promotes antitumor immunity","volume":"79","author":"Muralidhar","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2022.111757_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111613","article-title":"Hypomethylation associated vitamin D receptor expression in ATP1A1 mutant aldosterone-producing adenoma","volume":"548","author":"Nanao","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2022.111757_bib49","first-page":"1853","article-title":"The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity","volume":"11","author":"Nayeri","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2022.111757_bib50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/JME-18-0262","article-title":"Adrenocortical cancer cell line mutational profile reveals aggressive genetic background","volume":"62","author":"Nicolson","year":"2019","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.mce.2022.111757_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2184.1991.tb01146.x","article-title":"Differentiation-related regulation of 1,25-dihydroxyvitamin D3 receptor mRNA in human leukaemia cells HL-60","volume":"24","author":"Pan","year":"1991","journal-title":"Cell Prolif"},{"key":"10.1016\/j.mce.2022.111757_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.vh.2015.10.011","article-title":"Genomic determinants of vitamin D-regulated gene expression","volume":"100","author":"Pike","year":"2016","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.mce.2022.111757_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/375349","article-title":"Methylation status of vitamin D receptor gene promoter in benign and malignant adrenal tumors","author":"Pilon","year":"2015","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.mce.2022.111757_bib54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jsbmb.2013.11.008","article-title":"1\u03b1,25-Dihydroxyvitamin D\u2083 inhibits the human H295R cell proliferation by cell cycle arrest: a model for a protective role of vitamin D receptor against adrenocortical cancer","volume":"140","author":"Pilon","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2022.111757_bib55","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1158\/1078-0432.CCR-12-3354","article-title":"Establishment and characterization of the first pediatric adrenocortical carcinoma xenograft model identifies topotecan as a potential chemotherapeutic agent","volume":"19","author":"Pinto","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2022.111757_bib56","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1038\/ncomms7302","article-title":"Genomic landscape of paediatric adrenocortical tumours","volume":"6","author":"Pinto","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mce.2022.111757_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0303-7207(94)90277-1","article-title":"The NCI-H295 cell line: a pluripotent model for human adrenocortical studies","volume":"100","author":"Rainey","year":"1994","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2022.111757_bib58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/pbc.20318","article-title":"Biology, clinical characteristics, and management of adrenocortical tumors in children","volume":"45","author":"Rodriguez-Galindo","year":"2005","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.mce.2022.111757_bib59","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40618-019-01127-1","article-title":"The effects of mitotane and 1\u03b1,25-dihydroxyvitamin D3 on Wnt\/beta-catenin signaling in human adrenocortical carcinoma cells","volume":"43","author":"Rubin","year":"2020","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.mce.2022.111757_bib60","doi-asserted-by":"crossref","first-page":"11421","DOI":"10.18632\/oncotarget.3222","article-title":"Loss of \u03b2-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition","volume":"6","author":"Salomon","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2022.111757_bib61","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2019.20129","article-title":"Targeting the Wnt signalling pathway in cancer: prospects and perils","volume":"149","author":"Shaw","year":"2019","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.mce.2022.111757_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163962","article-title":"SeqKit: a cross-platform and ultrafast toolkit for fasta\/q file manipulation","volume":"11","author":"Shen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2022.111757_bib63","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","article-title":"Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences","volume":"4","author":"Soneson","year":"2015","journal-title":"F1000Res"},{"key":"10.1016\/j.mce.2022.111757_bib64","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1210\/en.2015-1466","article-title":"Pathogenesis of adrenal aldosterone-producing adenomas carrying mutations of the Na(+)\/K(+)-ATPase","volume":"156","author":"Stindl","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2022.111757_bib65","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1038\/onc.2010.80","article-title":"Meta-analysis of adrenocortical tumour genomics data: novel pathogenic pathways revealed","volume":"29","author":"Szab\u00f3","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2022.111757_bib66","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2022.111757_bib67","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1677\/ERC-09-0096","article-title":"Integrative molecular bioinformatics study of human adrenocortical tumors: MicroRNA, tissue-specific target prediction, and pathway analysis","volume":"16","author":"T\u00f6mb\u00f6l","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2022.111757_bib68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.devcel.2007.02.009","article-title":"A Wnt-CKIvarepsilon-Rap1 pathway regulates gastrulation by modulating SIPA1L1, a Rap GTPase activating protein","volume":"12","author":"Tsai","year":"2007","journal-title":"Dev. Cell"},{"key":"10.1016\/j.mce.2022.111757_bib69","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/01.ju.0000180645.89054.fd","article-title":"The impact of tumor stage on prognosis in children with adrenocortical carcinoma","volume":"174","author":"Tucci","year":"2005","journal-title":"J. Urol."},{"key":"10.1016\/j.mce.2022.111757_bib70","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1210\/endo.139.4.5892","article-title":"Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089","volume":"139","author":"VanWeelden","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2022.111757_bib75","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.mce.2022.111757_bib71","doi-asserted-by":"crossref","first-page":"20082","DOI":"10.1016\/S0021-9258(19)88668-4","article-title":"Up-regulation of the vitamin D receptor in response to 1,25-dihydroxyvitamin D3 results from ligand-induced stabilization","volume":"267","author":"Wiese","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2022.111757_bib72","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.mce.2022.111757_bib73","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1210\/me.2006-0015","article-title":"Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3","volume":"20","author":"Zella","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2022.111757_bib74","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1210\/me.2009-0140","article-title":"Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription","volume":"24","author":"Zella","year":"2010","journal-title":"Mol. Endocrinol."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720722002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720722002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:22:25Z","timestamp":1759587745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720722002052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":75,"alternative-id":["S0303720722002052"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2022.111757","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D receptor activation is a feasible therapeutic target to impair adrenocortical tumorigenesis","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2022.111757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111757"}}